Regeneration-associated utrophin expression in skeletal muscle: implications for utrophin-targeted therapies
- 1University of Oxford Department of Physiology Anatomy and Genetics
Abstract
Duchenne muscular dystrophy (DMD) is a lethal, X-linked muscle-wasting disease caused by loss of dystrophin. Utrophin, a structural and functional paralogue of dystrophin, can compensate for dystrophin deficiency and represents a therapeutic target applicable to patients irrespective of their DMD mutation. However, utrophin is also naturally upregulated at the sarcolemma of regenerating myofibres, creating an important confounding factor when utrophin levels are used to evaluate therapeutic activity. Here, we defined the temporal relationship between utrophin expression and complementary markers of skeletal muscle regeneration in wild-type and dystrophic mdx muscle following cardiotoxin-induced injury. Utrophin protein and mRNA dynamics were assessed together with dystrophin, embryonic myosin (MyHC-emb), centronucleation, cross-sectional area (CSA), and minimal Ferets diameter (MinFeret). MyHC-emb and utrophin were strongly associated with the early regenerative phase, although MyHC-emb peaked before maximal utrophin protein expression. In contrast, CSA and MinFeret showed an inverse temporal relationship with utrophin, while centronucleation persisted after active regeneration and did not discriminate early from late regenerative stages. Utrophin also remained elevated at the dystrophic sarcolemma for longer than in wild-type muscle. These findings demonstrate that utrophin quantification cannot be interpreted independently of the regenerative state of muscle. Combining MyHC-emb with morphological indices such as CSA and MinFeret provides a complementary framework for contextualizing regeneration-associated utrophin and should improve interpretation of utrophin changes in preclinical evaluation of utrophin-targeted therapies.
Related
- Biomaterials and Biological Therapies in Tympanic Membrane Regeneration: Systematic Review and Perspective
- A blastema in sea star larvae integrates wound signaling to drive regeneration-specific and developmental gene expression patterns.
- Ectopic expression of melanopsin promotes axonal regeneration in retinal ganglion cells via cAMP and TRPC signaling
- Clearing perivascular light chain-derived amyloid to counteract aging-associated decline in liver regeneration
- Comprehensive characterization of transposable element expression reveals regulatory circuitry and clinical implications in cancers
BibTeX
@misc{guiraud2026regenerationassociated,
title = {{Regeneration-associated utrophin expression in skeletal muscle: implications for utrophin-targeted therapies}},
author = {S. Guiraud and B. Edwards and S. E. Squire and K. E. Davies},
howpublished = {bioRxiv},
year = {2026},
month = sep,
doi = {10.64898/2026.09.10.750746},
url = {https://www.biorxiv.org/content/10.64898/2026.09.10.750746v1},
note = {CC BY},
}
RIS
TY - UNPB
TI - Regeneration-associated utrophin expression in skeletal muscle: implications for utrophin-targeted therapies
AU - S. Guiraud
AU - B. Edwards
AU - S. E. Squire
AU - K. E. Davies
PY - 2026
DA - 2026/09/10
PB - bioRxiv
DO - 10.64898/2026.09.10.750746
UR - https://www.biorxiv.org/content/10.64898/2026.09.10.750746v1
AB - Duchenne muscular dystrophy (DMD) is a lethal, X-linked muscle-wasting disease caused by loss of dystrophin. Utrophin, a structural and functional paralogue of dystrophin, can compensate for dystrophin deficiency and represents a therapeutic target applicable to patients irrespective of their DMD mutation. However, utrophin is also naturally upregulated at the sarcolemma of regenerating myofibres, creating an important confounding factor when utrophin levels are used to evaluate therapeutic activity. Here, we defined the temporal relationship between utrophin expression and complementary markers of skeletal muscle regeneration in wild-type and dystrophic mdx muscle following cardiotoxin-induced injury. Utrophin protein and mRNA dynamics were assessed together with dystrophin, embryonic myosin (MyHC-emb), centronucleation, cross-sectional area (CSA), and minimal Ferets diameter (MinFeret). MyHC-emb and utrophin were strongly associated with the early regenerative phase, although MyHC-emb peaked before maximal utrophin protein expression. In contrast, CSA and MinFeret showed an inverse temporal relationship with utrophin, while centronucleation persisted after active regeneration and did not discriminate early from late regenerative stages. Utrophin also remained elevated at the dystrophic sarcolemma for longer than in wild-type muscle. These findings demonstrate that utrophin quantification cannot be interpreted independently of the regenerative state of muscle. Combining MyHC-emb with morphological indices such as CSA and MinFeret provides a complementary framework for contextualizing regeneration-associated utrophin and should improve interpretation of utrophin changes in preclinical evaluation of utrophin-targeted therapies.
ER -